Esperion Therapeutics (ESPR) Q3 2023 Earnings

7NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.84
-0.68
-0.53
-0.37

Details

Expected EPS
-0.43
Actual EPS
-0.37
Surprise EPS
0.06
Surprise Percent
+13.95%

Description

Esperion Therapeutics (ESPR) has reported earnings of -0.37 per share for Q3 2023.

0 Comments

Share your thoughts